In Silico Identification of Novel Cancer Drugs with 3D Interaction Profiling
Cancer is a leading cause of death worldwide. Development of new cancer drugs is increasingly costly and time-consuming. By exploiting massive amounts of biological data, computational repositioning proposes new uses for old drugs to reduce these development hurdles. A promising approach is the syst...
Main Author: | |
---|---|
Other Authors: | |
Format: | Doctoral Thesis |
Language: | English |
Published: |
Saechsische Landesbibliothek- Staats- und Universitaetsbibliothek Dresden
2018
|
Subjects: | |
Online Access: | http://nbn-resolving.de/urn:nbn:de:bsz:14-qucosa-226435 http://nbn-resolving.de/urn:nbn:de:bsz:14-qucosa-226435 http://www.qucosa.de/fileadmin/data/qucosa/documents/22643/Dissertation_Salentin_Qucosa.pdf |
id |
ndltd-DRESDEN-oai-qucosa.de-bsz-14-qucosa-226435 |
---|---|
record_format |
oai_dc |
spelling |
ndltd-DRESDEN-oai-qucosa.de-bsz-14-qucosa-2264352018-08-02T03:28:43Z In Silico Identification of Novel Cancer Drugs with 3D Interaction Profiling Salentin, Sebastian Protein-Ligand Interaktionen Interaktionsmuster Drug Repositioning Krebs Virtuelles Screening Fingerprinting PDB protein-ligand interactions interaction patterns drug repositioning BVDU cancer virtual screening fingerprinting PDB ddc:540 rvk:VS 9107 Cancer is a leading cause of death worldwide. Development of new cancer drugs is increasingly costly and time-consuming. By exploiting massive amounts of biological data, computational repositioning proposes new uses for old drugs to reduce these development hurdles. A promising approach is the systematic analysis of structural data for identification of shared binding pockets and modes of action. In this thesis, I developed the Protein-Ligand Interaction Profiler (PLIP), which characterizes and indexes protein-ligand interactions to enable comparative analyses and searching in all available structures. Following, I applied PLIP to identify new treatment options in cancer: the heat shock protein Hsp27 confers resistance to drugs in cancer cells and is therefore an attractive target with a postulated drug binding site. Starting from Hsp27, I used PLIP to define an interaction profile to screen all structures from the Protein Data Bank (PDB). The top prediction was experimentally validated in vitro. It inhibits Hsp27 and significantly reduces resistance of multiple myeloma cells against the chemotherapeutic agent bortezomib. Besides computational repositioning, PLIP is used in docking, binding mode analysis, quantification of interactions and many other applications as evidenced by over 12,000 users so far. PLIP is provided to the community online and as open source. Saechsische Landesbibliothek- Staats- und Universitaetsbibliothek Dresden Technische Universität Dresden, Fakultät Informatik Prof. Dr. Michael Schroeder Prof. Dr. Michael Schroeder Prof. Dr. Andrew Torda 2018-08-01 doc-type:doctoralThesis application/pdf http://nbn-resolving.de/urn:nbn:de:bsz:14-qucosa-226435 urn:nbn:de:bsz:14-qucosa-226435 http://www.qucosa.de/fileadmin/data/qucosa/documents/22643/Dissertation_Salentin_Qucosa.pdf eng |
collection |
NDLTD |
language |
English |
format |
Doctoral Thesis |
sources |
NDLTD |
topic |
Protein-Ligand Interaktionen Interaktionsmuster Drug Repositioning Krebs Virtuelles Screening Fingerprinting PDB protein-ligand interactions interaction patterns drug repositioning BVDU cancer virtual screening fingerprinting PDB ddc:540 rvk:VS 9107 |
spellingShingle |
Protein-Ligand Interaktionen Interaktionsmuster Drug Repositioning Krebs Virtuelles Screening Fingerprinting PDB protein-ligand interactions interaction patterns drug repositioning BVDU cancer virtual screening fingerprinting PDB ddc:540 rvk:VS 9107 Salentin, Sebastian In Silico Identification of Novel Cancer Drugs with 3D Interaction Profiling |
description |
Cancer is a leading cause of death worldwide. Development of new cancer drugs is increasingly costly and time-consuming. By exploiting massive amounts of biological data, computational repositioning proposes new uses for old drugs to reduce these development hurdles. A promising approach is the systematic analysis of structural data for identification of shared binding pockets and modes of action.
In this thesis, I developed the Protein-Ligand Interaction Profiler (PLIP), which characterizes and indexes protein-ligand interactions to enable comparative analyses and searching in all available structures. Following, I applied PLIP to identify new treatment options in cancer: the heat shock protein Hsp27 confers resistance to drugs in cancer cells and is therefore an attractive target with a postulated drug binding site. Starting from Hsp27, I used PLIP to define an interaction profile to screen all structures from the Protein Data Bank (PDB). The top prediction was experimentally validated in vitro. It inhibits Hsp27 and significantly reduces resistance of multiple myeloma cells against the chemotherapeutic agent bortezomib.
Besides computational repositioning, PLIP is used in docking, binding mode analysis, quantification of interactions and many other applications as evidenced by over 12,000 users so far. PLIP is provided to the community online and as open source. |
author2 |
Technische Universität Dresden, Fakultät Informatik |
author_facet |
Technische Universität Dresden, Fakultät Informatik Salentin, Sebastian |
author |
Salentin, Sebastian |
author_sort |
Salentin, Sebastian |
title |
In Silico Identification of Novel Cancer Drugs with 3D Interaction Profiling |
title_short |
In Silico Identification of Novel Cancer Drugs with 3D Interaction Profiling |
title_full |
In Silico Identification of Novel Cancer Drugs with 3D Interaction Profiling |
title_fullStr |
In Silico Identification of Novel Cancer Drugs with 3D Interaction Profiling |
title_full_unstemmed |
In Silico Identification of Novel Cancer Drugs with 3D Interaction Profiling |
title_sort |
in silico identification of novel cancer drugs with 3d interaction profiling |
publisher |
Saechsische Landesbibliothek- Staats- und Universitaetsbibliothek Dresden |
publishDate |
2018 |
url |
http://nbn-resolving.de/urn:nbn:de:bsz:14-qucosa-226435 http://nbn-resolving.de/urn:nbn:de:bsz:14-qucosa-226435 http://www.qucosa.de/fileadmin/data/qucosa/documents/22643/Dissertation_Salentin_Qucosa.pdf |
work_keys_str_mv |
AT salentinsebastian insilicoidentificationofnovelcancerdrugswith3dinteractionprofiling |
_version_ |
1718715649531838464 |